Sign In
Buy VERU
$2.77
+0.440 (+18.88%)
At Close: Aug 10, 2026
Veru Inc. (VERU) Q1 2023 Earnings Call Transcript
03:28pm, Thursday, 11'th May 2023
Veru Inc. (NASDAQ:VERU ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations & Corporate Communications Mitchell Steiner -
Veru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimates
09:10am, Thursday, 11'th May 2023
Veru Inc. (VERU) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.18 per share a year ago.
VERU Stock Earnings: Veru Misses EPS, Beats Revenue Estimates
08:09am, Thursday, 11'th May 2023
Veru (NASDAQ: VERU ) just reported its fiscal second-quarter results. Veru reported a loss per share of 43 cents.
Is a Surprise Coming for Veru (VERU) This Earnings Season?
01:01pm, Tuesday, 09'th May 2023
Veru (VERU) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Veru to Report Fiscal 2023 Second Quarter Financial Results on May 11, 2023
06:45am, Thursday, 27'th Apr 2023
MIAMI, FL, April 27, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related disea
Advanced Penny Stocks Research Methods
11:00am, Sunday, 23'rd Apr 2023
Can these top tips help your penny stocks trading? The post Advanced Penny Stocks Research Methods appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is VERU Stock Up 3% Today?
10:41am, Friday, 21'st Apr 2023
Veru (NASDAQ: VERU ) stock is getting a boost on Friday after the company revealed plans to sell its ENTADFI capsule business. That sale has the company agreeing to sell the business for $20 million t
Top 5 Defensive Stocks That Are Set To Fly
07:37am, Friday, 24'th Mar 2023
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Veru to Present at the Oppenheimer 33rd Annual Healthcare Conference
08:30am, Tuesday, 07'th Mar 2023
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for on
Why Is Veru (VERU) Stock Down 37% Today?
09:23am, Friday, 03'rd Mar 2023
Veru (NASDAQ: VERU ) stock is taking a beating on Friday after the FDA denied the company's request for EUA for its Covid-19 treatment. That rejection has to do with sabizabulin, which is Veru's drug
Veru stock plummets toward 2 1/2-year low after FDA denies EUA request for COVID-19 treatment
07:00am, Friday, 03'rd Mar 2023
Share of Veru Inc. VERU, +0.53% plunged 31.0% toward a 2 1/2-year low in premarket Friday, after the U.S. Food and Drug Administration turned down the biopharmaceutical company's request for Emergency
Veru Inc.: Q1 Revenues Fall Short And Uncertainty Looms, Making It Risky
01:33pm, Monday, 27'th Feb 2023
Veru Inc. is eyeing emergency use authorization for its COVID-19 drug Sabizabulin, which is currently under FDA review. Veru Inc. shares fell around 20% to a 52-week low after reporting Q1 FY23 result
Veru Inc. (VERU) Q1 2023 Earnings Call Transcript
02:37pm, Thursday, 09'th Feb 2023
Veru Inc. (NASDAQ:VERU ) Q1 2023 Earnings Conference Call February 9, 2023 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations & Corporate Communications Mitchell Steine
Veru Inc. (VERU) Reports Q1 Loss, Misses Revenue Estimates
09:02am, Thursday, 09'th Feb 2023
Veru Inc. (VERU) delivered earnings and revenue surprises of -21.05% and 50.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023
08:30am, Thursday, 26'th Jan 2023
MIAMI, FL, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for onco
